Verrica Pharmaceuticals VRCA
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 8.31 | 102.65 | -0.65 | -7,192 | -8 | |
| 2025Q3 | 4.31 | 89.40 | -0.02 | 1,627 | 0 | |
| 2025Q2 | 5.30 | -0.01 | 1,510 | 0 | ||
| 2025Q1 | 4.42 | 107.84 | -1.00 | -8,130 | -10 | |
| 2024Q4 | 7.00 | 81.87 | -1.82 | -11,410 | -16 | |
| 2024Q3 | 14.50 | -4.90 | -20,704 | -23 | ||
| 2024Q2 | 72.90 | 102.62 | -3.70 | -15,206 | -17 | |
| 2024Q1 | 59.20 | 103.26 | -0.44 | -18,599 | -20 | |
| 2023Q4 | 73.20 | 93.12 | -0.54 | -23,136 | -25 | |
| 2023Q3 | 38.85 | 103.34 | -0.54 | -23,918 | -25 | |
| 2023Q2 | 57.70 | 105.70 | -0.25 | -11,616 | -11 | |
| 2023Q1 | 65.00 | 107.59 | -0.15 | -7,089 | -7 | |
| 2022Q4 | 27.50 | 104.70 | -0.14 | -6,211 | -6 | |
| 2022Q3 | 29.20 | 898.14 | 1.00 | 1,446 | 0 | |
| 2022Q2 | 19.20 | 99.62 | -3.70 | -9,121 | -10 | |
| 2022Q1 | 81.10 | 100.30 | -3.10 | -7,410 | -8 | |
| 2021Q4 | 91.60 | 100.32 | -3.50 | -8,470 | -10 | |
| 2021Q3 | 125.00 | 100.26 | -4.90 | -11,768 | -13 | |
| 2021Q2 | 113.00 | 100.31 | -4.20 | -10,730 | -12 | |
| 2021Q1 | 151.50 | 65.22 | -0.40 | 60 | -1 |